United States

Back to map

Showing 121-130 of 351 grants

Title Institution Researcher Program Duration Total Award Amount
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2024 to 31-October-2026 $250.000,00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2025 to 31-January-2027 $1.500.000,00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. The University of Chicago Piotr Witkowski Cures 01-September-2025 to 31-August-2029 $8.500.000,00
Engineered Nanoparticles for Beta Cell-Targeted Therapeutics The University of Chicago Raghavendra Mirmira Cures 01-April-2023 to 31-August-2026 $897.822,00
Expanding the Therapeutic and Targeting Capacity of Lipid Nanoparticles for Beta-Cell Protection The University of Chicago Raghavendra Mirmira Cures 01-September-2026 to 31-August-2028 $471.201,00
Project Tuyinza The Sonia Nabeta Foundation Vivian Nabeta Mission 01-April-2026 to 31-March-2029 $643.550,00
Quality, Equity & Outcomes Program The Sonia Nabeta Foundation Vivian Nabeta Mission 01-September-2026 to 31-August-2028 $1.400.000,00
Triple therapy for T1DM with insulin, semaglutide and dapagliflozin The Research Foundation of SUNY on behalf of University at Buffalo Paresh Dandona Improving Lives 01-January-2019 to 31-December-2026 $1.808.522,70
Targeting Complement-Driven Antigen Presentation in Tertiary Lymphoid Structures to Prevent Type 1 Diabetes The Regents of the University of California, San Francisco Anil Bhushan Cures 01-September-2026 to 31-August-2028 $498.142,00
Local delivery of immunomodulators to enable systemic immunosuppression-free efficient islet transplantation The Regents of the University of California, San Francisco Bhushan Kharbikar Cures 01-March-2024 to 28-February-2027 $285.000,00